<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240710121104&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240710121104&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 10 Jul 2024 16:11:05 +0000</lastbuilddate>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984491/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>Pathogenic variation in genes encoding proteins of the cardiac sarcomere is responsible for 30%-40% of cases of hypertrophic cardiomyopathy. The main clinical utility of genetic testing is to provide diagnostic confirmation and facilitation of family screening. It also assists in the detection of aetiologies, which require distinct monitoring and treatment approaches. Other clinical applications, including the use of genetic information to inform risk prediction models, have been limited by the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae421. doi: 10.1093/eurheartj/ehae421. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Pathogenic variation in genes encoding proteins of the cardiac sarcomere is responsible for 30%-40% of cases of hypertrophic cardiomyopathy. The main clinical utility of genetic testing is to provide diagnostic confirmation and facilitation of family screening. It also assists in the detection of aetiologies, which require distinct monitoring and treatment approaches. Other clinical applications, including the use of genetic information to inform risk prediction models, have been limited by the challenge of establishing robust genotype-phenotype correlations with actionable consequences, but new data on the interaction between rare and common genetic variation, as well as the emergence of therapies targeting disease-specific pathogenic mechanisms, herald a new era for genetic testing in routine practice.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984491/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984491</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae421>10.1093/eurheartj/ehae421</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984491</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Luis R Lopes</dc:creator>
<dc:creator>Carolyn Y Ho</dc:creator>
<dc:creator>Perry M Elliott</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice</dc:title>
<dc:identifier>pmid:38984491</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae421</dc:identifier>
</item>
<item>
<title>The ESC working group on pulmonary circulation and right ventricular function</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984436/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae297. doi: 10.1093/eurheartj/ehae297. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984436/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984436</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae297>10.1093/eurheartj/ehae297</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984436</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>George Giannakoulas</dc:creator>
<dc:creator>Frederikus A Klok</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The ESC working group on pulmonary circulation and right ventricular function</dc:title>
<dc:identifier>pmid:38984436</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae297</dc:identifier>
</item>
<item>
<title>Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984417/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>The rapid technological advancements in cardiac implantable electronic devices such as pacemakers, implantable cardioverter defibrillators, and loop recorders, coupled with a rise in the number of patients with these devices, necessitate an updated clinical framework for periprocedural management. The introduction of leadless pacemakers, subcutaneous and extravascular defibrillators, and novel device communication protocols underscores the imperative for clinical updates. This scientific...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 10. doi: 10.1161/CIR.0000000000001264. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The rapid technological advancements in cardiac implantable electronic devices such as pacemakers, implantable cardioverter defibrillators, and loop recorders, coupled with a rise in the number of patients with these devices, necessitate an updated clinical framework for periprocedural management. The introduction of leadless pacemakers, subcutaneous and extravascular defibrillators, and novel device communication protocols underscores the imperative for clinical updates. This scientific statement provides an inclusive framework for the periprocedural management of patients with these devices, encompassing the planning phase, procedure, and subsequent care coordinated with the primary device managing clinic. Expert contributions from anesthesiologists, cardiac electrophysiologists, and cardiac nurses are consolidated to appraise current evidence, offer patient and health system management strategies, and highlight key areas for future research. The statement, pertinent to a wide range of health care professionals, underscores the importance of quality care pathways for patient safety, optimal device function, and minimization of hemodynamic disturbances or arrhythmias during procedures. Our primary objective is to deliver quality care to the expanding patient cohort with cardiac implanted electronic devices, offering direction in the era of evolving technologies and laying a foundation for sustained education and practice enhancement.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984417/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984417</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001264>10.1161/CIR.0000000000001264</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984417</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Elaine Y Wan</dc:creator>
<dc:creator>Albert J Rogers</dc:creator>
<dc:creator>Michael Lavelle</dc:creator>
<dc:creator>Mason Marcus</dc:creator>
<dc:creator>Sarah A Stone</dc:creator>
<dc:creator>Linda Ottoboni</dc:creator>
<dc:creator>Uma Srivatsa</dc:creator>
<dc:creator>Miguel A Leal</dc:creator>
<dc:creator>Andrea M Russo</dc:creator>
<dc:creator>Larry R Jackson</dc:creator>
<dc:creator>George H Crossley</dc:creator>
<dc:creator>American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Peripheral Vascular Disease</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38984417</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001264</dc:identifier>
</item>
<item>
<title>Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984412/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae330. doi: 10.1093/eurheartj/ehae330. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984412/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984412</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae330>10.1093/eurheartj/ehae330</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984412</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Yevgeniy Kreinin</dc:creator>
<dc:creator>Mark Epshtein</dc:creator>
<dc:creator>Gil Bolotin</dc:creator>
<dc:creator>Netanel Korin</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project</dc:title>
<dc:identifier>pmid:38984412</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae330</dc:identifier>
</item>
<item>
<title>Rising stars in cardiology: Srividya Velagapudi</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984410/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae328. doi: 10.1093/eurheartj/ehae328. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984410/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984410</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae328>10.1093/eurheartj/ehae328</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984410</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Rising stars in cardiology: Srividya Velagapudi</dc:title>
<dc:identifier>pmid:38984410</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae328</dc:identifier>
</item>
<item>
<title>Welcome to the exciting world of the right ventricle</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984401/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae377. doi: 10.1093/eurheartj/ehae377. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984401/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984401</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae377>10.1093/eurheartj/ehae377</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984401</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Julia Grapsa</dc:creator>
<dc:creator>Edoardo Zancanaro</dc:creator>
<dc:creator>Maurice Enriquez-Sarano</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Welcome to the exciting world of the right ventricle</dc:title>
<dc:identifier>pmid:38984401</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae377</dc:identifier>
</item>
<item>
<title>The ESC Working Group on e-Cardiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984398/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae332. doi: 10.1093/eurheartj/ehae332. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984398/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984398</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae332>10.1093/eurheartj/ehae332</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984398</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Ruben Casado Arroyo</dc:creator>
<dc:creator>Magnus T Jensen</dc:creator>
<dc:creator>Polychronis Dilaveris</dc:creator>
<dc:creator>Emanuela T Locati</dc:creator>
<dc:creator>Raffaele De Lucia</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The ESC Working Group on e-Cardiology</dc:title>
<dc:identifier>pmid:38984398</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae332</dc:identifier>
</item>
<item>
<title>Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984394/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093/eurheartj/ehae383. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984394/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984394</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae383>10.1093/eurheartj/ehae383</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984394</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Ovidio A García-Villarreal</dc:creator>
<dc:creator>Amedeo Anselmi</dc:creator>
<dc:creator>Sylvain Beurtheret</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery</dc:title>
<dc:identifier>pmid:38984394</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae383</dc:identifier>
</item>
<item>
<title>Investing in value-based primary care: a pathway to sustainable healthcare</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984386/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae404. doi: 10.1093/eurheartj/ehae404. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984386/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984386</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae404>10.1093/eurheartj/ehae404</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984386</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Kevin Cheng</dc:creator>
<dc:creator>Luigi Fontana</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Investing in value-based primary care: a pathway to sustainable healthcare</dc:title>
<dc:identifier>pmid:38984386</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae404</dc:identifier>
</item>
<item>
<title>Time matters when considering treatment for patients with mitral regurgitation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38984374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093/eurheartj/ehae384. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38984374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38984374</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae384>10.1093/eurheartj/ehae384</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38984374</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Anne Bernard</dc:creator>
<dc:creator>Pierre Deharo</dc:creator>
<dc:creator>Laurent Fauchier</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Time matters when considering treatment for patients with mitral regurgitation</dc:title>
<dc:identifier>pmid:38984374</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae384</dc:identifier>
</item>
<item>
<title>Risk scores in congenital long QT syndrome: friend or foe?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38982981/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae408. doi: 10.1093/eurheartj/ehae408. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38982981/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38982981</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae408>10.1093/eurheartj/ehae408</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38982981</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Arthur A M Wilde</dc:creator>
<dc:creator>Christian van der Werf</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Risk scores in congenital long QT syndrome: friend or foe?</dc:title>
<dc:identifier>pmid:38982981</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae408</dc:identifier>
</item>
<item>
<title>Iron replacement in anthracycline-related cardiac dysfunction: fuel on the fire?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38982980/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae411. doi: 10.1093/eurheartj/ehae411. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38982980/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38982980</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae411>10.1093/eurheartj/ehae411</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38982980</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Muhummad Sohaib Nazir</dc:creator>
<dc:creator>Alexander R Lyon</dc:creator>
<dc:creator>Richard Southworth</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Iron replacement in anthracycline-related cardiac dysfunction: fuel on the fire?</dc:title>
<dc:identifier>pmid:38982980</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae411</dc:identifier>
</item>
<item>
<title>Heart failure with preserved ejection fraction therapy: combining sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38982938/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 10:ehae414. doi: 10.1093/eurheartj/ehae414. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38982938/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38982938</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae414>10.1093/eurheartj/ehae414</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38982938</guid>
<pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>John W Ostrominski</dc:creator>
<dc:creator>Scott D Solomon</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:date>2024-07-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Heart failure with preserved ejection fraction therapy: combining sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists</dc:title>
<dc:identifier>pmid:38982938</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae414</dc:identifier>
</item>
<item>
<title>A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38981482/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>Cellular senescence is an irreversible state of cell-cycle arrest induced by various stresses, including aberrant oncogene activation, telomere shortening, and DNA damage. Through a genome-wide screen, we discovered a conserved small nucleolar RNA (snoRNA), SNORA13, that is required for multiple forms of senescence in human cells and mice. Although SNORA13 guides the pseudouridylation of a conserved nucleotide in the ribosomal decoding center, loss of this snoRNA minimally impacts translation....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 28:S0092-8674(24)00693-7. doi: 10.1016/j.cell.2024.06.019. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cellular senescence is an irreversible state of cell-cycle arrest induced by various stresses, including aberrant oncogene activation, telomere shortening, and DNA damage. Through a genome-wide screen, we discovered a conserved small nucleolar RNA (snoRNA), SNORA13, that is required for multiple forms of senescence in human cells and mice. Although SNORA13 guides the pseudouridylation of a conserved nucleotide in the ribosomal decoding center, loss of this snoRNA minimally impacts translation. Instead, we found that SNORA13 negatively regulates ribosome biogenesis. Senescence-inducing stress perturbs ribosome biogenesis, resulting in the accumulation of free ribosomal proteins (RPs) that trigger p53 activation. SNORA13 interacts directly with RPL23, decreasing its incorporation into maturing 60S subunits and, consequently, increasing the pool of free RPs, thereby promoting p53-mediated senescence. Thus, SNORA13 regulates ribosome biogenesis and the p53 pathway through a non-canonical mechanism distinct from its role in guiding RNA modification. These findings expand our understanding of snoRNA functions and their roles in cellular signaling.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38981482/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38981482</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.019>10.1016/j.cell.2024.06.019</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38981482</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Yujing Cheng</dc:creator>
<dc:creator>Siwen Wang</dc:creator>
<dc:creator>He Zhang</dc:creator>
<dc:creator>Jong-Sun Lee</dc:creator>
<dc:creator>Chunyang Ni</dc:creator>
<dc:creator>Jason Guo</dc:creator>
<dc:creator>Eric Chen</dc:creator>
<dc:creator>Shenming Wang</dc:creator>
<dc:creator>Asha Acharya</dc:creator>
<dc:creator>Tsung-Cheng Chang</dc:creator>
<dc:creator>Michael Buszczak</dc:creator>
<dc:creator>Hao Zhu</dc:creator>
<dc:creator>Joshua T Mendell</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence</dc:title>
<dc:identifier>pmid:38981482</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.019</dc:identifier>
</item>
<item>
<title>All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38981481/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>All-RNA-mediated targeted gene integration methods, rendering reduced immunogenicity, effective deliverability with non-viral vehicles, and a low risk of random mutagenesis, are urgently needed for next-generation gene addition technologies. Naturally occurring R2 retrotransposons hold promise in this context due to their site-specific integration profile. Here, we systematically analyzed the biodiversity of R2 elements and screened several R2 orthologs capable of full-length gene insertion in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 1:S0092-8674(24)00694-9. doi: 10.1016/j.cell.2024.06.020. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">All-RNA-mediated targeted gene integration methods, rendering reduced immunogenicity, effective deliverability with non-viral vehicles, and a low risk of random mutagenesis, are urgently needed for next-generation gene addition technologies. Naturally occurring R2 retrotransposons hold promise in this context due to their site-specific integration profile. Here, we systematically analyzed the biodiversity of R2 elements and screened several R2 orthologs capable of full-length gene insertion in mammalian cells. Robust R2 system gene integration efficiency was attained using combined donor RNA and protein engineering. Importantly, the all-RNA-delivered engineered R2 system showed effective integration activity, with efficiency over 60% in mouse embryos. Unbiased high-throughput sequencing demonstrated that the engineered R2 system exhibited high on-target integration specificity (99%). In conclusion, our study provides engineered R2 tools for applications based on hit-and-run targeted DNA integration and insights for further optimization of retrotransposon systems.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38981481/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38981481</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.020>10.1016/j.cell.2024.06.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38981481</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Yangcan Chen</dc:creator>
<dc:creator>Shengqiu Luo</dc:creator>
<dc:creator>Yanping Hu</dc:creator>
<dc:creator>Bangwei Mao</dc:creator>
<dc:creator>Xinge Wang</dc:creator>
<dc:creator>Zongbao Lu</dc:creator>
<dc:creator>Qingtong Shan</dc:creator>
<dc:creator>Jin Zhang</dc:creator>
<dc:creator>Siqi Wang</dc:creator>
<dc:creator>Guihai Feng</dc:creator>
<dc:creator>Chenxin Wang</dc:creator>
<dc:creator>Chen Liang</dc:creator>
<dc:creator>Na Tang</dc:creator>
<dc:creator>Rui Niu</dc:creator>
<dc:creator>Jiaqiang Wang</dc:creator>
<dc:creator>Jiabao Han</dc:creator>
<dc:creator>Ning Yang</dc:creator>
<dc:creator>Haoyi Wang</dc:creator>
<dc:creator>Qi Zhou</dc:creator>
<dc:creator>Wei Li</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>Cell</dc:source>
<dc:title>All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons</dc:title>
<dc:identifier>pmid:38981481</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.020</dc:identifier>
</item>
<item>
<title>Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38981480/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 2:S0092-8674(24)00692-5. doi: 10.1016/j.cell.2024.06.018. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p &lt; 1e-16) and disorders linked to altered gut ecology (p &lt; 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p &lt; 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38981480/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38981480</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.018>10.1016/j.cell.2024.06.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38981480</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Elisa Piperni</dc:creator>
<dc:creator>Long H Nguyen</dc:creator>
<dc:creator>Paolo Manghi</dc:creator>
<dc:creator>Hanseul Kim</dc:creator>
<dc:creator>Edoardo Pasolli</dc:creator>
<dc:creator>Sergio Andreu-Sánchez</dc:creator>
<dc:creator>Alberto Arrè</dc:creator>
<dc:creator>Kate M Bermingham</dc:creator>
<dc:creator>Aitor Blanco-Míguez</dc:creator>
<dc:creator>Serena Manara</dc:creator>
<dc:creator>Mireia Valles-Colomer</dc:creator>
<dc:creator>Elco Bakker</dc:creator>
<dc:creator>Fabio Busonero</dc:creator>
<dc:creator>Richard Davies</dc:creator>
<dc:creator>Edoardo Fiorillo</dc:creator>
<dc:creator>Francesca Giordano</dc:creator>
<dc:creator>George Hadjigeorgiou</dc:creator>
<dc:creator>Emily R Leeming</dc:creator>
<dc:creator>Monia Lobina</dc:creator>
<dc:creator>Marco Masala</dc:creator>
<dc:creator>Andrea Maschio</dc:creator>
<dc:creator>Lauren J McIver</dc:creator>
<dc:creator>Mauro Pala</dc:creator>
<dc:creator>Maristella Pitzalis</dc:creator>
<dc:creator>Jonathan Wolf</dc:creator>
<dc:creator>Jingyuan Fu</dc:creator>
<dc:creator>Alexandra Zhernakova</dc:creator>
<dc:creator>Simone M Cacciò</dc:creator>
<dc:creator>Francesco Cucca</dc:creator>
<dc:creator>Sarah E Berry</dc:creator>
<dc:creator>Danilo Ercolini</dc:creator>
<dc:creator>Andrew T Chan</dc:creator>
<dc:creator>Curtis Huttenhower</dc:creator>
<dc:creator>Tim D Spector</dc:creator>
<dc:creator>Nicola Segata</dc:creator>
<dc:creator>Francesco Asnicar</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries</dc:title>
<dc:identifier>pmid:38981480</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.018</dc:identifier>
</item>
<item>
<title>Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38980800/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 9:ehae399. doi: 10.1093/eurheartj/ehae399. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38980800/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38980800</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae399>10.1093/eurheartj/ehae399</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38980800</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Faiez Zannad</dc:creator>
<dc:creator>João Pedro Ferreira</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there</dc:title>
<dc:identifier>pmid:38980800</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae399</dc:identifier>
</item>
<item>
<title>A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38979959/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 9;45(26):2267-2270. doi: 10.1093/eurheartj/ehae405.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38979959/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38979959</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae405>10.1093/eurheartj/ehae405</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38979959</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome</dc:title>
<dc:identifier>pmid:38979959</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae405</dc:identifier>
</item>
<item>
<title>Innovative therapeutic targets in cardio-oncology and a Great Debate in heart failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38979806/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 9;45(25):2171-2174. doi: 10.1093/eurheartj/ehae397.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38979806/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38979806</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae397>10.1093/eurheartj/ehae397</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38979806</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Innovative therapeutic targets in cardio-oncology and a Great Debate in heart failure</dc:title>
<dc:identifier>pmid:38979806</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae397</dc:identifier>
</item>
<item>
<title>L-Wnk1 Deletion in Smooth Muscle Cells Causes Aortitis and Inflammatory Shift</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38979610/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Wnk1 is a key regulator of VSMC function. Wnk1 deletion promotes VSMC phenotype switch toward a pathogenic proinflammatory phenotype, orchestrating deleterious vascular remodeling and spontaneous severe aortitis in mice.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jul 9. doi: 10.1161/CIRCRESAHA.124.324366. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The long isoform of the Wnk1 (with-no-lysine [K] kinase 1) is a ubiquitous serine/threonine kinase, but its role in vascular smooth muscle cells (VSMCs) pathophysiology remains unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: AngII (angiotensin II) was infused in <i>Apoe</i><sup><i>-/-</i></sup> to induce experimental aortic aneurysm. Mice carrying an <i>Sm22-Cre</i> allele were cross-bred with mice carrying a floxed <i>Wnk1</i> allele to specifically investigate the functional role of Wnk1 in VSMCs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Single-cell RNA-sequencing of the aneurysmal abdominal aorta from AngII-infused <i>Apoe</i><sup><i>-/-</i></sup> mice revealed that VSMCs that did not express Wnk1 showed lower expression of contractile phenotype markers and increased inflammatory activity. Interestingly, WNK1 gene expression in VSMCs was decreased in human abdominal aortic aneurysm. <i>Wnk1</i>-deficient VSMCs lost their contractile function and exhibited a proinflammatory phenotype, characterized by the production of matrix metalloproteases, as well as cytokines and chemokines, which contributed to local accumulation of inflammatory macrophages, Ly6C<sup>hi</sup> monocytes, and γδ T cells. <i>Sm22Cre+Wnk1</i><sup><i>lox/lox</i></sup> mice spontaneously developed aortitis in the infrarenal abdominal aorta, which extended to the thoracic area over time without any negative effect on long-term survival. AngII infusion in <i>Sm22Cre+Wnk1</i><sup><i>lox/lox</i></sup> mice aggravated the aortic disease, with the formation of lethal abdominal aortic aneurysms. Pharmacological blockade of γδ T-cell recruitment using neutralizing anti-CXCL9 antibody treatment, or of monocyte/macrophage using Ki20227, a selective inhibitor of CSF1 receptor, attenuated aortitis. <i>Wnk1</i> deletion in VSMCs led to aortic wall remodeling with destruction of elastin layers, increased collagen content, and enhanced local TGF-β (transforming growth factor-beta) 1 expression. Finally, in vivo TGF-β blockade using neutralizing anti-TGF-β antibody promoted saccular aneurysm formation and aorta rupture in <i>Sm22 Cre+ Wnk1</i><sup><i>lox/lox</i></sup> mice but not in control animals.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Wnk1 is a key regulator of VSMC function. <i>Wnk1</i> deletion promotes VSMC phenotype switch toward a pathogenic proinflammatory phenotype, orchestrating deleterious vascular remodeling and spontaneous severe aortitis in mice.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38979610/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38979610</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324366>10.1161/CIRCRESAHA.124.324366</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38979610</guid>
<pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Helene Quelquejay</dc:creator>
<dc:creator>Rida Al-Rifai</dc:creator>
<dc:creator>Michele Silvestro</dc:creator>
<dc:creator>Marie Vandestienne</dc:creator>
<dc:creator>Irmine Ferreira</dc:creator>
<dc:creator>Tristan Mirault</dc:creator>
<dc:creator>Henrion Daniel</dc:creator>
<dc:creator>Xiaodan Zhong</dc:creator>
<dc:creator>Icia Santos-Zas</dc:creator>
<dc:creator>Guillaume Goudot</dc:creator>
<dc:creator>Paul Alayrac</dc:creator>
<dc:creator>Estelle Robidel</dc:creator>
<dc:creator>Gwennhael Autret</dc:creator>
<dc:creator>Daniel Balvay</dc:creator>
<dc:creator>Soraya Taleb</dc:creator>
<dc:creator>Alain Tedgui</dc:creator>
<dc:creator>Chantal M Boulanger</dc:creator>
<dc:creator>Alma Zernecke</dc:creator>
<dc:creator>Antoine-Emmanuel Saliba</dc:creator>
<dc:creator>Juliette Hadchouel</dc:creator>
<dc:creator>Bhama Ramkhelawon</dc:creator>
<dc:creator>Clement Cochain</dc:creator>
<dc:creator>Sonia Bergaya</dc:creator>
<dc:creator>Xavier Jeunemaitre</dc:creator>
<dc:creator>Hafid Ait-Oufella</dc:creator>
<dc:date>2024-07-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>L-Wnk1 Deletion in Smooth Muscle Cells Causes Aortitis and Inflammatory Shift</dc:title>
<dc:identifier>pmid:38979610</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324366</dc:identifier>
</item>
<item>
<title>Correction to: Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target against Ischemic Heart Failure in Prediabetic Animals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38976615/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240710121104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 9;150(2):e63. doi: 10.1161/CIR.0000000000001270. Epub 2024 Jul 8.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38976615/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240710121104&v=2.18.0.post9+e462414">38976615</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001270>10.1161/CIR.0000000000001270</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38976615</guid>
<pubDate>Mon, 08 Jul 2024 06:00:00 -0400</pubDate>
<dc:date>2024-07-08</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target against Ischemic Heart Failure in Prediabetic Animals</dc:title>
<dc:identifier>pmid:38976615</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001270</dc:identifier>
</item>





























</channel>
</rss>